McKesson Corporation $MCK Shares Sold by Accurate Wealth Management LLC

Accurate Wealth Management LLC lowered its stake in shares of McKesson Corporation (NYSE:MCK) by 22.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,044 shares of the company’s stock after selling 884 shares during the quarter. Accurate Wealth Management LLC’s holdings in McKesson were worth $2,484,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Brighton Jones LLC increased its stake in McKesson by 46.3% during the fourth quarter. Brighton Jones LLC now owns 2,523 shares of the company’s stock valued at $1,438,000 after purchasing an additional 798 shares during the last quarter. Caxton Associates LLP acquired a new position in McKesson in the first quarter valued at approximately $233,000. Sivia Capital Partners LLC grew its holdings in shares of McKesson by 77.9% during the second quarter. Sivia Capital Partners LLC now owns 685 shares of the company’s stock valued at $502,000 after purchasing an additional 300 shares during the last quarter. American Century Companies Inc. raised its position in shares of McKesson by 16.0% during the 2nd quarter. American Century Companies Inc. now owns 13,718 shares of the company’s stock worth $10,052,000 after purchasing an additional 1,895 shares during the period. Finally, J.W. Cole Advisors Inc. increased its position in McKesson by 6.7% in the second quarter. J.W. Cole Advisors Inc. now owns 3,760 shares of the company’s stock worth $2,755,000 after buying an additional 236 shares during the period. Institutional investors own 85.07% of the company’s stock.

Wall Street Analysts Forecast Growth

MCK has been the topic of several recent research reports. Wall Street Zen upgraded shares of McKesson from a “hold” rating to a “buy” rating in a research report on Sunday, March 22nd. Raymond James Financial set a $970.00 price target on shares of McKesson in a research note on Thursday, March 5th. Wells Fargo & Company lifted their price target on McKesson from $914.00 to $925.00 and gave the company an “equal weight” rating in a report on Thursday, February 5th. Robert W. Baird set a $968.00 price objective on McKesson in a research report on Wednesday, January 14th. Finally, Weiss Ratings cut McKesson from a “buy (a-)” rating to a “buy (b+)” rating in a research report on Thursday, February 5th. Thirteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat, McKesson presently has an average rating of “Moderate Buy” and a consensus price target of $960.93.

McKesson Stock Performance

NYSE MCK opened at $860.41 on Friday. The firm’s 50 day moving average price is $907.62 and its two-hundred day moving average price is $838.81. McKesson Corporation has a twelve month low of $637.00 and a twelve month high of $999.00. The stock has a market cap of $105.39 billion, a price-to-earnings ratio of 24.75, a PEG ratio of 1.39 and a beta of 0.38.

McKesson (NYSE:MCK) last issued its earnings results on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, topping the consensus estimate of $9.19 by $0.15. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The business had revenue of $106.16 billion during the quarter, compared to analysts’ expectations of $105.98 billion. During the same quarter last year, the firm posted $8.03 earnings per share. McKesson’s revenue was up 11.4% compared to the same quarter last year. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, research analysts forecast that McKesson Corporation will post 32.77 EPS for the current fiscal year.

McKesson Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be issued a dividend of $0.82 per share. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. The ex-dividend date is Monday, March 2nd. McKesson’s dividend payout ratio (DPR) is currently 9.43%.

Insider Buying and Selling at McKesson

In related news, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the business’s stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $955.00, for a total transaction of $313,240.00. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Maria Martinez sold 349 shares of the company’s stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $939.87, for a total value of $328,014.63. Following the completion of the transaction, the director directly owned 301 shares in the company, valued at approximately $282,900.87. The trade was a 53.69% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 3,868 shares of company stock valued at $3,743,820 in the last 90 days. Corporate insiders own 0.08% of the company’s stock.

McKesson Company Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.